_ _
Ajay K. Banga, Ph.D.


Page 1 | Page 2
________________________________Ajay K. Banga, Ph.D .:. Home___

Selected Publications

  • H. Nguyen and A. Banga, Enhanced skin delivery of vismodegib by microneedle treatment, Drug Delivery and Translational Research, in press

  • A. Sivaraman and A. Banga, Quality by design (QbD) approaches for topical dermatological dosage forms, Research & Reports in Transdermal Drug Delivery, in press.

  • M. Gujjar and A. Banga, Iontophoretic and Microneedle mediated transdermal delivery of glycopyrrolate, Pharmaceutics, in press.

  • A. Herwadkar, V. Sachdeva, L.F. Taylor, H. Silver, and A.K. Banga. Low frequency sonophoresis mediated transdermal and intradermal delivery of ketoprofen, International Journal of Pharmaceutics, 423( (2) (2012) 289-96. 

  • Transcending the skin barrier to deliver peptides and proteins using active technologies, N.Singh, H. Kalluri, A. Herwadkar, A. Badkar, and A. Banga, Crit.Rev.Ther.Drug Carr.Syst., 29 (4) (2012) 265-298. 

  • Peptide and protein transdermal drug delivery, A. Herwadkar and A. Banga, Drug Discovery Today: Technologies, in press. 

  • C. Tas, S.Mansoor, H.Kalluri, V.Zarnitsyn, S.Choi, A.Banga, and M.Prausnitz, Delivery of salmon calcitonin using a microneedle patch, International Journal of Pharmaceutics, in press. 

  • Iontophoresis of a 13 kDa protein monitored by subcutaneous microdialysis in vivo, S. Katikaneni, P. Kasha, A. Badkar, and A. Banga, Bioanalysis, 3(21) (2011) 2419-2426. 

  • In vitro and in vivo iontophoretic transdermal delivery of an anti-parkinsonian agent, V. Vemulapalli, Y. Yang, S. Siddoju, R. Conjeevaram, H. Teunissen, T. Myers, and A. Banga, International Journal of Pharmaceutics, 420(1) (2011) 20-25. 

  • Characterization of microchannels created by metal microneedles: Formation and closure, H. Kalluri, C. Kolli, and A. Banga, The AAPS Journal, 13 (3) (2011) 473-481.

  • Iontophoretic delivery of acyclovir: Intradermal drug monitoring using microdialysis and quantification by skin extraction, S. Siddoju, V. Sachdeva, P. Friden, and A. Banga, PDA Journal of Pharmaceutical Sciences and Technology, 65 (5) (2011) 432-444. 

  • Enhanced delivery of cosmeceuticals by microdermabrasion, Y.Zhou and A. Banga, Journal of Cosmetic Dermatology, 10 (3)  (2011) 179-184. 

  • Effects of chemical and physical enhancement techniques on transdermal delivery of cyanocobalamin (vitamin B12) in vitro, Y. Yang, H. Kalluri, and A. Banga, Pharmaceutics, 3(3) (2011) 474-484. 

  • Microneedles and their applications, V. Sachdeva and A. Banga, Recent Patents on Drug Delivery and Formulation, 5(2) (2011) 95-132. 

  • Transdermal delivery of proteins, H. Kalluri and A. Banga, AAPS PharmSciTech, 12(1) (2011) 431-441.

  • Acyclovir skin depot characterization following in vivo iontophoretic delivery, S. Siddoju, V. Sachdeva, P. Friden, Y.Yu, and A. Banga, Skin Res. Technology, 17(2) (2011) 234-244. 

  • Iontophoresis mediated in vivo intradermal delivery of terbinafine hydrochloride, V. Sachdeva,  H.Kim, P.Friden, and A. Banga, Int J.Pharm, 393 (2010) 112-8. 

  • Transdermal and intradermal iontophoretic delivery of dexamethasone sodium phosphate: Quantification of the drug localized in skin, J. Paturi, H.Kim, B.Chakraborty, P.Friden, and A. Banga, J. Drug Target., 18(2) (2010) 134-140 

  • Inhibition of crystallization in drug-in-adhesive type Transdermal patches, P. Jain and A. Banga, International Journal of Pharmaceutics, 394 (2010) 68-74. 

  • Transdermal delivery of a 13 kDa protein: An in vivo comparison of physical enhancement methods , S. Katikaneni, G.Li, A. Badkar, and A. Banga,  J.Drug Target., 18 (2010) 141-147. 

  • Enhancement of transdermal delivery of heparin by various physical and chemical enhancement techniques, S. Lanke, J. Strom, and A. Banga, Critical Reviews in Therapeutic Drug Carrier Systems, 26 (2009) 581-606.

  • Formation and closure of microchannels in skin following microporation, H. Kalluri and A. Banga, Pharmaceutical Research, in press.

  • Transdermal iontophoretic delivery of terbinafine hydrochloride: Quantitation of drug levels in stratum corneum and underlying skin, V. Sachdeva, S. Siddoju, Y.Yu, H.Kim, P.Friden, and A. Banga, Int J.Pharm, 388 (2010) 24-31.

  • Microchannels created by sugar and metal microneedles: Characterization by microscopy, macromolecular flux, and other techniques, G.Li, A.Badkar, H.Kalluri, and A. Banga, J. Pharm. Sci., 99 (2010) 1931-41.

  • Microneedle-mediated Transdermal delivery: How to contribute to meaningful research to advance this growing field, A. Banga, Transdermal Magazine, 1 (1) (2009) 8-13.

  • Microneedles and transdermal drug delivery, H. Kalluri and A. Banga, J. Drug Del. Sci. Technol., 19(5) (2009) 303-310.

  • Transdermal and intradermal iontophoretic delivery of dexamethasone sodium phosphate: Quantification of the drug localized in skin, J. Paturi, H.Kim, B.Chakraborty, P.Friden, and A. Banga*, J. Drug Target., in press. 

  • Molecular charge mediated transport of a 13 kDa protein across microporated skin, S. Katikaneni, A. Badkar, S. Nema, and A. Banga, Int. J. Pharm, 378 (2009) 93-100. 

  • Microporation applications for enhancing drug delivery, A. Banga, Expert Opin. Drug Deliv. 6(4) (2009) 1-12. 

  • In vitro transdermal delivery of therapeutic antibodies using maltose microneedles , G.Li, A. Badkar, S. Nema, C. Kolli, and A. Banga, Int. J. Pharm, 368 (2009) 109-115.  

  • In vitro transdermal iontophoretic delivery of penbutolol sulfate, K. Ita and A. Banga, Drug Delivery, 16 (2009) 11-14. 

  • Enhanced transdermal delivery of low molecular weight heparin by barrier perturbation, S. Lanke, C. Kolli, J. Strom, and A. Banga*, Int. J. Pharm, 365 (2009) 26-33. 

  • Optimization of iontophoretic parameters for the transdermal delivery of methotrexate, V. Vemulapalli, P. Friden, and A. Banga*, Drug Delivery, 15 (2008) 437-442. 

  • Biochemical enhancement of transdermal delivery with magainin peptide: Modification of electrostatic interactions by changing pH, Y. Kim, S. Late, A. Banga, P. Ludovice and M. Prausnitz, Int. J. Pharm., 362 (2008) 20-28.

  • A review of patent literature for iontophoretic delivery and devices, P. Kasha and A. Banga*, Recent Patents on Drug Delivery & Formulation, 2 (2008) 41-50. 

  • Characterization of solid maltose microneedles and their use for transdermal delivery, C. Kolli and A. Banga*, Pharmaceutical Research, 25 (2008) 104-113.

  • Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate, V. Vemulapalli, Y. Yang, P. Friden, and A. Banga*, J Pharm Pharmacol, 60 (2008) 27-33  

  • Transdermal delivery of interferon alpha-2B using microporation and iontophoresis in hairless rats, A. Badkar, A. Smith, J. Eppstein, and A. Banga, Pharmaceutical Research, 24 (7) (2007) 1389-1395.

  • New Technologies to Allow Transdermal Delivery of Therapeutic Proteins and Small Water-Soluble Drugs, A. Banga, American Journal of Drug Delivery, 4:221-230 (2006).

  • Dermal, subdermal, and systemic concentrations of granisetron hydrochloride by iontophoretic delivery, A. Chaturvedula, D. P. Joshi, C. Anderson, R. Morris, W.L. Sembrowich, and A.K. Banga, Pharmaceutical Research, 22 (2005) 1313-1319.

  • In vivo iontophoretic delivery and pharmacokinetics of salmon calcitonin, A. Chaturvedula, D. P. Joshi, C. Anderson, R. Morris, W.L. Sembrowich, and A.K. Banga, Int. J. Pharm., 297 (2005) 190-196.

  • Factorial design approach to evaluate interactions between electrically assisted enhancement and skin stripping for delivery of tacrine, A. C. Hirsch, R.S. Upasani, and A.K. Banga, J.Control.Rel., 103 (1) (2005) 113-121.

  • Response surface methodology to investigate the iontophoretic delivery of tacrine hydrochloride, R.S. Upasani and A.K. Banga, Pharmaceutical Research, 21 (12) (2004) 2293-2299.

  • Iontophoretic in vivo transdermal delivery of beta-blockers in hairless rats and reduced skin irritation by liposomal formulation, R. Conjeevaram, A. Chaturvedula, G.V. Betageri, G. Sunkara, and A.K. Banga, Pharm Res, 20 (2003) 1496-1501.

  • Stability of a transdermal salmon calcitonin formulation, S.Chang, G.A. Hofmann, L. Zhang, L.J. Deftos, and A.K. Banga, Drug Delivery, 10 (2003) 41-45.

  • Electrically modulated transdermal delivery of fentanyl, Raj Conjeevaram, Ajay K. Banga, and Lei Zhang, Pharm. Res.., 19 (2002) 440-444.

  • Electrically enhanced transdermal delivery of a macromolecule, A.V. Badkar and A.K. Banga, J. Pharm. Pharmacol., 54 (2002) 907-912.

Page 1 | Page 2

 

 
 
Copyright 2007 ©Mercer University
All Rights Reserved